Search results for ' Oxford'

Ranbir, Alia join the Kapoors for Christmas brunch

Ranbir, Alia join the Kapoors for Christmas brunch

Rediff.com25 Dec 2020

Ranbir revealed to journalist Rajeev Masand the other day that Alia and he would have gotten married this year, but for the pandemic.

Recovered people showing faster response to Covishield: Study

Recovered people showing faster response to Covishield: Study

Rediff.com3 Mar 2021

Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India's corona immunisation cover.

UK identifies new South African coronavirus variant

UK identifies new South African coronavirus variant

Rediff.com24 Dec 2020

Like the UK variant identified earlier, the new variant of the novel coronavirus is also driving a massive resurgence of the disease in South Africa, with experts warning the country is probably facing a much larger second wave.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

India, UK unveil 10-year roadmap to boost trade

India, UK unveil 10-year roadmap to boost trade

Rediff.com4 May 2021

Britain has finalised 1 billion pounds worth of new trade and investment with India, creating over 6,500 jobs in the UK, to be signed off at a virtual summit between Prime Minister Boris Johnson and his Indian counterpart Narendra Modi on Tuesday. The investments confirmed by Downing Street on Monday evening form part of an Enhanced Trade Partnership (ETP), which will set the ambition to double the value of UK-India trade by 2030 and declare a shared intent to begin work towards a comprehensive Free Trade Agreement (FTA). "Like every aspect of the UK-India relationship, the economic links between our countries make our people stronger and safer," Johnson said.

India to supply Covid vaccines to 6 countries as aid

India to supply Covid vaccines to 6 countries as aid

Rediff.com19 Jan 2021

In a tweet, Prime Minister Narendra Modi said India is deeply honoured to be a 'long-trusted' partner in meeting the healthcare needs of the global community and that supplies of the vaccines to several countries will commence on Wednesday, and more will follow in the days ahead.

447 reported adverse effects after Covid-19 vaccination: Govt

447 reported adverse effects after Covid-19 vaccination: Govt

Rediff.com17 Jan 2021

Out of the 447 adverse events following immunisation, only 3 required hospitalisation.

Harsh Vardhan, Cong's Manish Tewari spar over nod to Covaxin

Harsh Vardhan, Cong's Manish Tewari spar over nod to Covaxin

Rediff.com16 Jan 2021

Senior Congress leader Manish Tewari and Union Health Minister Harsh Vardhan sparred on Twitter on Saturday with the Opposition leader raising questions over the emergency use approval given to the indigenously developed vaccine Covaxin and the Bharatiya Janata Party leader hitting back alleging that Tewari was only passionate about spreading rumours.

Bharat Biotech has two more Covid vaccines in pipeline

Bharat Biotech has two more Covid vaccines in pipeline

Rediff.com16 Jan 2021

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India.

Serum Institute began its journey in a small lab in stud farm

Serum Institute began its journey in a small lab in stud farm

Rediff.com16 Jan 2021

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

PM to launch COVID vaccination drive on Jan 16 at 10.30 am

PM to launch COVID vaccination drive on Jan 16 at 10.30 am

Rediff.com14 Jan 2021

Modi is also likely to launch the Co-WIN (COVID Vaccine Intelligence Network) App, a digital platform created for real-time monitoring of COVID-19 vaccine delivery and distribution.

Serum Institute set to sign deal with Centre for Covishield

Serum Institute set to sign deal with Centre for Covishield

Rediff.com9 Dec 2020

By January-February, it's expected to have at least 100 million doses for the Indian government, reports Sohini Das.

Covishield: 'Single dose gives 71% effectiveness'

Covishield: 'Single dose gives 71% effectiveness'

Rediff.com20 Jul 2021

'You have sufficient protection if you take the second dose of the Covishield vaccine at 12 weeks, because this vaccine works in a way where it provides protection in the first dose.'

Bharat Biotech seeks emergency nod for use of Covaxin

Bharat Biotech seeks emergency nod for use of Covaxin

Rediff.com8 Dec 2020

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Serum seeks emergency use for its COVID-19 vaccine

Serum seeks emergency use for its COVID-19 vaccine

Rediff.com7 Dec 2020

SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global pharma giant AstraZeneca and Oxford University.

Govt places order for 11 mn doses of Serum vaccine Covishield

Govt places order for 11 mn doses of Serum vaccine Covishield

Rediff.com11 Jan 2021

Dispatch of the vaccine is likely to start by early Tuesday morning, sources said. According to the order placed, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210.

Renowned writer Ved Mehta, who took India to Americans, passes away at 86

Renowned writer Ved Mehta, who took India to Americans, passes away at 86

Rediff.com11 Jan 2021

Born in pre-partition Lahore to a well-off Punjabi family in 1934, Mehta lost his eyesight when he was three years old to meningitis. He, however, did not let his impairment get in the way of a flourishing career or stop him from showcasing his literary prowess to the world.

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

Indian economy to rebound with 8.9% growth in FY22

Indian economy to rebound with 8.9% growth in FY22

Rediff.com8 Jan 2021

Indian economy is likely to rebound with an 8.9 per cent growth in the fiscal year beginning April 2021 after economic activity showed significant improvement in the last quarter, IHS Markit said on Friday. The National Statistical Organisation (NSO) on Thursday predicted that the economy will contract 7.7 per cent in the current financial year ending in March, the worst performance in four decades.

Second dry run for Covid vaccine across India on January 8

Second dry run for Covid vaccine across India on January 8

Rediff.com6 Jan 2021

The first dry run of the vaccination drive took place across 125 districts covering all States/UTs on January 2. The dry run was also conducted to familiarise the state, district, block, and hospital-level officers on all aspects of the COVID-19 rollout.

Incident with volunteer no way induced by vaccine: Serum Institute

Incident with volunteer no way induced by vaccine: Serum Institute

Rediff.com1 Dec 2020

A Chennai-based man has demanded a compensation of Rs 5 crore from the SII after his health worsened allegedly after volunteering for the clinical trials for a COVID-19 vaccine.

Speedy distribution of vaccine major global challenge: WHO experts

Speedy distribution of vaccine major global challenge: WHO experts

Rediff.com5 Jan 2021

As India launches the world's most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire population, two prominent Indian scientists at World Health Organisation have said.

PM to visit 3 COVID-19 vaccine development sites on Saturday

PM to visit 3 COVID-19 vaccine development sites on Saturday

Rediff.com27 Nov 2020

Modi on Saturday will embark on a three-city tour to take stock of the COVID-19 vaccine development work.

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

Rediff.com27 Nov 2020

On Tuesday, Rao said there was a possibility of the PM's visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.

AIIMS chief among volunteers for Covaxin's phase-3 trial

AIIMS chief among volunteers for Covaxin's phase-3 trial

Rediff.com26 Nov 2020

The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.

Sensex ends 195 pts higher; Nifty tops 12,900

Sensex ends 195 pts higher; Nifty tops 12,900

Rediff.com23 Nov 2020

ONGC was the top gainer in the Sensex pack, surging around 7 per cent, followed by IndusInd Bank, Infosys, Tech Mahindra, Reliance Industries, HCL Tech and TCS. On the other hand, HDFC, ICICI Bank, Axis Bank, SBI and M&M were among the laggards.

China eyes excellence at Winter Olympics

China eyes excellence at Winter Olympics

Rediff.com3 Feb 2021

China has smothered most outbreaks within its borders, keeping new case numbers low.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'

Healthcare workers, those above 65 yrs to be given vaccine first: Govt

Healthcare workers, those above 65 yrs to be given vaccine first: Govt

Rediff.com19 Nov 2020

Health Minister Harsh Vardhan said the COVID-19 vaccine will be available in the next few months and it is estimated that by July-August 400-500 million doses will be made available for 25-30 crore people.

Dry run for Covid inoculation next week

Dry run for Covid inoculation next week

Rediff.com26 Dec 2020

An important focus of the dry run will be on management of any possible adverse events following immunisation.

UN chief lauds India's COVID-19 vaccine assistance to nations

UN chief lauds India's COVID-19 vaccine assistance to nations

Rediff.com29 Jan 2021

India has airlifted more than 6 million COVID-19 doses to nine countries in Phase-I under its initiative termed "Vaccine Maitri".

'India examining possibilities': Govt on Pfizer Covid vaccine

'India examining possibilities': Govt on Pfizer Covid vaccine

Rediff.com17 Nov 2020

The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.

PM trashes politics over vaccine, says he went by scientists' advice

PM trashes politics over vaccine, says he went by scientists' advice

Rediff.com22 Jan 2021

Health practitioners who have been vaccinated against coronavirus or have administered the shots to others took part, sharing their first-hand experiences.

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.

US polls generated highest voter turnout rate in 120 years

US polls generated highest voter turnout rate in 120 years

Rediff.com6 Nov 2020

The November 3 election saw a record voter turnout of 66.9 per cent, which is the highest turnout rate since 1900. The 1900 election had recorded 73.7 per cent voter turnout

No cess on Covid-19 vaccination; but rich may be charged

No cess on Covid-19 vaccination; but rich may be charged

Rediff.com5 Nov 2020

There was speculation that a one-time special Covid-19 cess would be imposed and that it would raise an estimated Rs 18,000 crore.

India's first mRNA vaccine gets nod for human trials

India's first mRNA vaccine gets nod for human trials

Rediff.com12 Dec 2020

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.

Docs join duty soon after getting jabbed

Docs join duty soon after getting jabbed

Rediff.com16 Jan 2021

Messages of congratulations, doctors posing with a victory sign for the media with their infectious smiles -- visible even under the cover of mask -- and the many 'just got jabbed' selfie by the health workers, it was a rare and happy day at the BLK hospital, which has witnessed many dreary days in the past due to the ongoing pandemic.

Prev  |  Next